Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

13.26
Delayed Data
As of Jul 20
 +0.16 / +1.22%
Today’s Change
8.18
Today|||52-Week Range
15.20
+34.21%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close13.10
Today’s open13.13
Day’s range13.03 - 13.51
Volume763,158
Average volume (3 months)1,204,161
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 07/20/2017

Growth & Valuation

Earnings growth (last year)-224.00%
Earnings growth (this year)-24.44%
Earnings growth (next 5 years)+13.27%
Revenue growth (last year)+8.61%
P/E ratioNM
Price/Sales8.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc-0.12-0.28%
ONCESpark Therapeutics I...+1.13+1.76%
BPMCBlueprint Medicines ...+1.27+2.38%
MNTAMomenta Pharmaceutic...+0.35+2.07%
Data as of 4:00pm ET, 07/20/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$146.7M
Annual profit (last year)-$103.0M
Net profit margin-70.23%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts